266 related articles for article (PubMed ID: 19843035)
21. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation.
Prendergast MB; Gaston RS
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1305-11. PubMed ID: 20448067
[TBL] [Abstract][Full Text] [Related]
22. Outcomes and Risk Factors for Graft Loss: Lessons Learned from 1,056 Pediatric Kidney Transplants at the University of Minnesota.
Chinnakotla S; Verghese P; Chavers B; Rheault MN; Kirchner V; Dunn T; Kashtan C; Nevins T; Mauer M; Pruett T;
J Am Coll Surg; 2017 Apr; 224(4):473-486. PubMed ID: 28254584
[TBL] [Abstract][Full Text] [Related]
23. A Medication Adherence Promotion System to Reduce Late Kidney Allograft Rejection: A Quality Improvement Study.
Hooper DK; Varnell CD; Rich K; Carle A; Huber J; Mostajabi F; Dahale D; Pai ALH; Goebel J; Modi AC
Am J Kidney Dis; 2022 Mar; 79(3):335-346. PubMed ID: 34352285
[TBL] [Abstract][Full Text] [Related]
24. Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.
Neff RT; Jindal RM; Yoo DY; Hurst FP; Agodoa LY; Abbott KC
Transplantation; 2009 Jul; 88(1):135-41. PubMed ID: 19584693
[TBL] [Abstract][Full Text] [Related]
25. The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study.
Chesnaye NC; van Stralen KJ; Bonthuis M; Groothoff JW; Harambat J; Schaefer F; Canpolat N; Garnier A; Heaf J; de Jong H; Schwartz Sørensen S; Tönshoff B; Jager KJ
Nephrol Dial Transplant; 2017 Nov; 32(11):1949-1956. PubMed ID: 28992338
[TBL] [Abstract][Full Text] [Related]
26. Age-specific risk of renal graft loss from late acute rejection or non-compliance in the adolescent and young adult period.
Ritchie AG; Clayton PA; McDonald SP; Kennedy SE
Nephrology (Carlton); 2018 Jun; 23(6):585-591. PubMed ID: 28452103
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
28. Association of medication non-adherence with short-term allograft loss after the treatment of severe acute kidney transplant rejection.
Al-Sheyyab A; Binari L; Shwetar M; Ramos E; Kapp ME; Bala S; Wilson N; Forbes RC; Helderman JH; Abdel-Kader K; Concepcion BP
BMC Nephrol; 2019 Oct; 20(1):373. PubMed ID: 31623566
[TBL] [Abstract][Full Text] [Related]
29. Renal transplant patient compliance with free immunosuppressive medications.
Chisholm MA; Vollenweider LJ; Mulloy LL; Jagadeesan M; Wynn JJ; Rogers HE; Wade WE; DiPiro JT
Transplantation; 2000 Oct; 70(8):1240-4. PubMed ID: 11063348
[TBL] [Abstract][Full Text] [Related]
30. Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States.
Gharibi Z; Ayvaci MUS; Hahsler M; Giacoma T; Gaston RS; Tanriover B
Transplantation; 2017 Jun; 101(6):1234-1241. PubMed ID: 27379555
[TBL] [Abstract][Full Text] [Related]
31. Long-term pancreas allograft survival in simultaneous pancreas-kidney transplantation by era.
Waki K; Sugawara Y; Kokudo N; Kadowaki T
Clin Transpl; 2012; ():13-22. PubMed ID: 23721007
[TBL] [Abstract][Full Text] [Related]
32. Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.
Wang CS; Gander J; Patzer RE; Greenbaum LA
Am J Kidney Dis; 2018 Mar; 71(3):392-398. PubMed ID: 29277509
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with graft survival in South African adolescent renal transplant patients at CMJAH over a 20-year period (GRAFT-SAT Study).
Chhiba PD; Moore DP; Levy C; Do Vale C
Pediatr Transplant; 2022 Feb; 26(1):e14148. PubMed ID: 34569127
[TBL] [Abstract][Full Text] [Related]
34. Time-dependent variability in tacrolimus trough blood levels is a risk factor for late kidney transplant failure.
Sapir-Pichhadze R; Wang Y; Famure O; Li Y; Kim SJ
Kidney Int; 2014 Jun; 85(6):1404-11. PubMed ID: 24336032
[TBL] [Abstract][Full Text] [Related]
35. Noncompliance with immunnosuppressive medications after renal transplantation.
Ghods AJ; Nasrollahzadeh D
Exp Clin Transplant; 2003 Jun; 1(1):39-47. PubMed ID: 15859906
[TBL] [Abstract][Full Text] [Related]
36. Transition to adult care for pediatric liver transplant recipients: the Western Australian experience.
Mitchell T; Gooding H; Mews C; Adams L; MacQuillan G; Garas G; Ravikumara M; Lopez A; Collins M; Jeffrey G
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27762479
[TBL] [Abstract][Full Text] [Related]
37. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study.
Weng LC; Yang YC; Huang HL; Chiang YJ; Tsai YH
J Adv Nurs; 2017 Jan; 73(1):228-239. PubMed ID: 27532342
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.
Page TF; Woodward RS
Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):435-44. PubMed ID: 19817527
[TBL] [Abstract][Full Text] [Related]
40. Morbid obesity is not an independent predictor of graft failure or patient mortality after kidney transplantation.
Pieloch D; Dombrovskiy V; Osband AJ; Lebowitz J; Laskow DA
J Ren Nutr; 2014 Jan; 24(1):50-7. PubMed ID: 24070588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
